CLABSI Prevention Bundle Implementation

Key Points

  • CLABSI prevention relies on consistent execution of core bundle elements.
  • Core elements include hand hygiene, barrier precautions, optimal insertion-site selection, and daily review of line need.
  • Maintenance reliability depends on hub/connector disinfection and dressing-timing discipline (gauze about every 48 hours, transparent semipermeable dressing about every 7 days, or sooner if loose/soiled/damp).
  • Dressing changes should follow aseptic nontouch technique (ANTT): protect key parts/key sites, use sterile field discipline, and avoid avoidable contamination.
  • The bundle is evaluated with all-or-none completion.
  • Daily necessity review is critical to reduce unnecessary central-line exposure.

Equipment

  • Hand-hygiene supplies and sterile barrier kit (or prepackaged sterile CVAD dressing kit when available)
  • Sterile transparent semipermeable or gauze dressing supplies, securement device, and skin-barrier product
  • Sterile needleless connectors, sterile disinfectant caps, and preservative-free prefilled normal-saline syringes
  • Central-line insertion/maintenance checklist
  • Daily line-necessity review documentation tool

Procedure Steps

  1. Perform hand hygiene before any central-line procedure or manipulation.
  2. Ensure maximal barrier precautions during insertion activities.
  3. Confirm optimal catheter site selection per policy and patient factors (for adults, avoid femoral placement when clinically feasible).
  4. Before dressing care, review baseline line data (including prior external catheter length and last dressing date) and skin-product allergies (for example chlorhexidine or adhesive sensitivity), prepare an aseptic field, and use masks for clinician and client; have family/visitors mask if present per policy.
  5. Measure external catheter length through the intact dressing, then remove old dressing with nonsterile gloves by lifting from the hub edge and pulling toward the insertion site to reduce dislodgement risk; remove securement device as indicated, then perform hand hygiene and don sterile gloves.
  6. Use chlorhexidine-based skin antisepsis for insertion and dressing care per policy; if chlorhexidine is contraindicated, use approved alternatives (for example povidone-iodine) and allow full dry time.
  7. Cleanse insertion site with friction (commonly back-and-forth for about 30 seconds while covering horizontal/vertical planes) and let antiseptic dry naturally before applying new dressing/securement (do not wipe, fan, or blow).
  8. Maintain aseptic line access technique during all handling and disinfect hubs/connectors/injection ports with friction before each access.
  9. During connector changes, prime new needleless connector with sterile saline per policy, keep the catheter clamp closed during connector exchange, scrub hub, attach/tighten new connector, then unclamp and verify patency/flush.
  10. Use approved antiseptic-impregnated protective caps when available and replace after access per policy.
  11. Stabilize the line with approved securement (suture or sutureless device by policy) to reduce dislodgement and insertion-site trauma.
  12. Keep dressing intact and dry; change gauze dressings about every 48 hours and transparent semipermeable dressings about every 7 days, or immediately when damp, loose, or visibly soiled.
  13. Complete daily review of line necessity with provider/team.
  14. Promptly escalate and remove line when no longer clinically indicated.
  15. Document completion of each bundle element using checklist format, including dressing date/time/initials and next due change, connector-cap change details by lumen/time, patient tolerance/teaching, and pre/post line metrics when obtained (for example external catheter length and PICC arm-circumference trend).
  16. Mark bundle complete only when all required elements are met.

Common Errors

  • Skipping daily necessity review prolonged line exposure risk.
  • Inconsistent barrier practice contamination risk increase.
  • Partial checklist completion documented as complete false adherence signal.
  • Delayed line removal after indication ends preventable CLABSI risk.